PhD Position in Developing Hydrogels, ICMAB-CSIC, Barcelona, Spain

Postdoc in Spain

SummPhD Position in Developing Hydrogels: The ICMAB is offering a PhD position under the MaTrans42 Severo Ochoa project focusing on the development of innovative hydrogels to improve cancer radiotherapy. The project aims to address critical challenges in treating lung and glioblastoma cancers through advanced soft materials, providing a unique opportunity for interdisciplinary research.

PhD Position in Developing Hydrogels to Battle Cancer through Radiotherapy (HyRad)

Designation

PhD Researcher in Bionanomaterials for Cancer Research

DetailInformation
Research AreaSoft Materials and Cancer Research
LocationICMAB-CSIC, Barcelona, Spain
Eligibility/QualificationMaster’s degree in relevant fields
Start DateApproximately September 2025
Application DeadlineAugust 31, 2025

Research Area

The focus will be on developing hydrogels for enhanced radiotherapy responses and minimizing effects on healthy tissues. The project includes collaboration with various hospitals and usage of patient-derived cancer organoids.

Location

Barcelona, Spain at the Institute of Materials Science of Barcelona (ICMAB-CSIC).

Eligibility/Qualification

Candidates should possess:

  • A Master’s degree in Biotechnology, Biomedicine, Chemistry, Materials Science, Nanotechnology, or related fields.
  • A high level of motivation and capability for teamwork.
  • Proficiency in oral and written English.
  • Preferred experience in synthesis and characterization of biomaterials, particularly nanoparticles and hydrogels.
  • Experience in cell culture, optical and fluorescence microscopy, and flow cytometry is a plus.

Description

The PhD candidate will work on synthesizing and characterizing novel bionanomaterials, including functional nanoparticles and 3D hydrogels. The role involves:

  • Utilizing various techniques such as NMR, IR, X-ray tomography, rheology, SEM, TEM, DLS, and confocal microscopy.
  • Conducting cell culture studies to develop patient-derived lung cancer organoids in partnership with the Hospital General Universitari de Valencia.
  • Analyzing cancer organoids through a range of methodologies and evaluating the incorporation of radiotherapeutic agents into the treatments.
  • Participation in national and international conferences and receiving training in leadership and soft skills.

How to Apply

Interested candidates should send their application materials, including a CV and cover letter, to the following email addresses:

Last Date for Apply

August 31, 2025

This PhD position represents a unique opportunity to contribute to significant advancements in cancer treatment using innovative biomaterials.

Link

LEAVE A REPLY

Please enter your comment!
Please enter your name here